Ifeoma Ulasi
A5053475701- Dialysis and Renal Disease Management
- Chronic Kidney Disease and Diabetes
- Organ Donation and Transplantation
- Healthcare cost, quality, practices
- Health Systems, Economic Evaluations, Quality of Life
- Renal and Vascular Pathologies
- Renal Diseases and Glomerulopathies
- Health Literacy and Information Accessibility
- Mobile Health and mHealth Applications
- Global Health Care Issues
- Healthcare Systems and Reforms
- Social Media in Health Education
- Blood Pressure and Hypertension Studies
- Global Public Health Policies and Epidemiology
- Global Maternal and Child Health
- Nutritional Studies and Diet
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Biomedical Ethics and Regulation
- Healthcare Policy and Management
- Public Health in Brazil
- Palliative Care and End-of-Life Issues
- HIV-related health complications and treatments
- Sodium Intake and Health
- Organ Transplantation Techniques and Outcomes
- Liver Disease Diagnosis and Treatment
University of Nigeria Teaching Hospital
2016-2025
University of Nigeria
2011-2024
Federal Teaching Hospital Abakaliki
2013-2024
Boston University
2024
University of Ibadan
2021-2024
Duke University
2024
University of Ilorin
2024
Wake Forest University
2024
RELX Group (United States)
2020-2023
Enugu State University of Science and Technology
2022
This article is published as part of a supplement sponsored by Kidney Disease: Improving Global Outcomes (KDIGO). The opinions or views expressed in this are those the authors and do not necessarily reflect recommendations International Society Nephrology Elsevier. Dosages, indications, methods use for products that referred to may their clinical experience be derived from professional literature other sources.
BackgroundChronic kidney disease is an important cause of global mortality and morbidity. Data for epidemiological features chronic its risk factors are limited low-income middle-income countries. The International Society Nephrology's Kidney Disease Center (ISN-KDDC) aimed to assess the prevalence awareness factors, investigate cardiovascular disease, in countries low middle income.MethodsWe did a cross-sectional study 12 from six world regions: Bangladesh, Bolivia, Bosnia Herzegovina,...
HIV-positive individuals are at increased risk for kidney disease, including HIV-associated nephropathy, noncollapsing focal segmental glomerulosclerosis, immune-complex and comorbid as well injury resulting from prolonged exposure to antiretroviral therapy or opportunistic infections. Clinical guidelines disease prevention treatment in largely extrapolated studies the general population, do not fully incorporate existing knowledge of unique HIV-related pathways genetic factors that...
The Kidney Disease: Improving Global Outcomes (KDIGO) Clinical Practice Guideline for the Evaluation and Management of Chronic Disease (CKD) updates KDIGO 2012 guideline has been developed with patient partners, clinicians, researchers around world, using robust methodology. This update, based on a substantially broader base evidence than previously available, reflects an exciting time in nephrology. New therapies strategies have tested large diverse populations that help to inform care;...
Historically, it takes an average of 17 years to move new treatments from clinical evidence daily practice. Given the highly effective now available prevent or delay kidney disease onset and progression, this is far too long. The time narrow gap between what we know do. Clear guidelines exist for prevention management common risk factors disease, such as hypertension diabetes, but only a fraction people with these conditions worldwide are diagnosed, even fewer treated target. Similarly, vast...
Background . The magnitude of the problem chronic kidney disease (CKD) is enormous, and prevalence keeps rising. To highlight burden CKD in developing countries, authors looked at end-stage renal (ESRD) patients seen University Nigeria Teaching Hospital (UNTH), Enugu, South-East Nigeria. Method ESRD from 01/05/1990 to 31/12/2003 were recruited. Records A&E Department, medical-out-patients, wards dialysis unit used. Results A total 1001 male versus 537 female reviewed. About 593 315 had...
The prevalence of cardio-metabolic syndrome (CMS) is increasing worldwide. In people African descent, there higher hypertension and complications than other races. Bearing in mind these facts, we looked at the CMS general population with hypertension. Using new International Diabetes Federation (IDF) definitions CMS, studied its semi-urban rural communities South-east Nigeria relation to This a cross sectional based study involving 1458 adults aged from 25 64 years. Diagnosis was on IDF...
Background . A community-based study put the prevalence of hypertension in Nigeria at 32.8%. Market workers lead sedentary life style and often depend on salt-laden fast food while work. Method An unselected population market were screened for its risk factors by a pretested, structured questionnaire, clinical examination, laboratory investigation. Hypertension was defined as BP ≥ 140 and/or 90 mmHg or being drug therapy. Results Forty-two percent hypertensive. Of this number, 70.6% did not...
Around 850 million people currently are affected by different types of kidney disorders.1International Society Nephrology2019 United Nations High Level Meeting on UHC: Moving Together to Build Kidney Health worldwide; 2019.https://www.theisn.org/images/Advocacy_4_pager_2019_Final_WEB_pagebypage.pdfDate accessed: July 20, 2019Google Scholar Up 1 in 10 adults worldwide has chronic disease (CKD), which is invariably irreversible and mostly progressive. The global burden CKD increasing,...
Kidney failure is an important outcome for patients, clinicians, researchers, healthcare systems, payers, and regulators. However, no harmonized international consensus definitions of kidney key surrogates progression to exist specifically clinical trials. The International Society Nephrology convened multi-stakeholder meeting develop on this topic. A core group, experienced in design, conduct, adjudication trials, developed a database 64 randomized trials the 163 included relevant failure....
Apolipoprotein L1 gene (
The Kidney Disease: Improving Global Outcomes (KDIGO) organization updated its existing clinical practice guideline in 2024 to provide guidance on the evaluation, management, and treatment of chronic kidney disease (CKD) adults children who are not receiving replacement therapy.
<b><i>Background:</i></b> Continental Africa is facing an epidemic of chronic kidney disease (CKD). APOL1 risk variants have been shown to be strongly associated with increased for non-diabetic including HIV nephropathy, primary non-monogenic focal and segmental glomerulosclerosis, hypertension-attributed nephropathy among African ancestry populations in the USA. The world's highest frequencies alleles reported West nations, overlapping regions a high incidence CKD...
Living with chronic kidney disease (CKD) is associated hardships for patients and their care partners. Empowering partners, including family members friends involved in care, may help minimize the burden consequences of CKD-related symptoms to enable increased life participation. There a need broaden focus on living well reengagement life, emphasis patient being control. The World Kidney Day (WKD) Joint Steering Committee has declared 2021 year "Living Well Disease" an effort increase...
Preclinical tests in animal models are key steps early drug development. Consequently, the International Society of Nephrology held a consensus meeting that connected experts global kidney community order to provide guidance on optimal management translational studies for development new drugs treat disease, entitled "TRANSFORM; TRAnslational Science FOR Medications." The covered various themes, including following: (i) selection disease model; (ii) pharmacokinetics; (iii) interventions late...
Hypertension is the leading modifiable cardiovascular risk factor with recognized sex- and gender-based differences. We assessed incorporation of sex gender reporting in antihypertensive medication literature informing hypertension guidelines.